Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ikena Oncology, Inc.

1.11
+0.0000
Post-market: 1.110.00000.00%16:00 EDT
Volume:138.59K
Turnover:154.85K
Market Cap:53.57M
PE:-1.09
High:1.17
Open:1.14
Low:1.07
Close:1.11
Loading ...
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2022

Correspondence

CORRESP [Cover] - Correspondence
Apr 13, 2022

Major Issues Report

8-K - Current report
Apr 06, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 28, 2022

Major Issues Report

8-K - Current report
Jan 26, 2022

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 12, 2021

Major Issues Report

8-K - Current report